Overall, our results provide a compelling insight into the role of iron regulation in malaria, especially site-specific ferroportin expression (hepatic vs. RBC) during malaria, highlighting hepcidin-FPN axis as a potential therapeutic target. This evidence concerns the gene SLC40A1 and malaria.